 CAMBRIDGE, Mass.--BUSINESS WIRE--Syros Pharmaceuticals NASDAQ:SYRS, a leader in the development of medicines that control the expression of genes, today announced that members of its management team will participate in panel discussions and present a corporate overview at upcoming investor conferences. Details are as follows: Cowen and Company 41st Annual Health Care Conference Date: Monday, March 1 Panel Title: Novel Oncology Targets Panel Time: 1:20 p.m. ET 33rd Annual Roth Conference Dat 